Without a doubt, the synchronization of public health intervention on health issues along the
international border will enhance the control of epidemic-prone disease and other health …

In this paper, we present a multicentre record-based descriptive study used to estimate the
incidence and characterize the spectrum of confirmed bacille Calmette–Guérin (BCG) …

BACKGROUND: Bacillus Calmette-Guérin (BCG) vaccine-related complications are
frequently observed in children in Oman. There are a few regional studies on BCG …

PMID: 22156632 DOI: 10.5144/0256-4947.2012. 1 clearly demonstrated an increasing rate
of lymphadenitis from 1.96/1000 to 10.14/1000, which was associated with BCG SSI vaccine …

OBJECTIVE: To assess the impact of rescheduling of BCG vaccination from the current twice
weekly to daily to cover newborn vaccinations at the Government Medical College, Patiala …

Bacillus Calmette–Guérin (BCG) vaccine provides good protection against disseminated
mycobacterial diseases such as miliary tuberculosis, tuberculous meningitis, and leprosy [1 …

Background Bacillus Calmette Guerin (BCG) is the only available vaccine for tuberculosis
(TB). Low grade complications in healthy recipients and disseminated vaccine associated …

Objectives To identify determinants of Bacillus Calmette–Guérin (BCG) vaccination among
children born in Québec, Canada, in 1974, the last year of the systematic vaccination …

Abstract Background The Bacillus Calmette-Guérin (BCG) vaccine is recommended at birth
in Guinea-Bissau but often given with delay. Delays are not evident in routine coverage …

Introduction Malaria continues to be a major cause of morbidity and mortality in sub-Saharan
Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine …